Epilepsia

14/04/2026
Real-world effectiveness and tolerability of highly purified cannabidiol in patients with monogenic developmental and epileptic encephalopathies with highly active epilepsy
Epilepsia
Download PDF here 
07/07/2025
A Multicenter study on the use of purified cannabidiol for children with treatment – resistant developmental and epileptic encephalopathies (551 patient)
Epilepsia
Summary: Study analyzing the efficacy and safety of purified cannabidiol (Convupidiol®) as an add-on therapy in 551 ch...
05/01/2025
Expanding The Therapeutic role of highly purified cannabidiol in monogenic epilepsies : A multicenter real world study
Epilepsia
Summary: An international study evaluating the efficacy of purified cannabidiol (Epidiolex/Convupidiol) in 266 patients wi...
30/11/2024
Population pharmacokinetics of cannabidiol and the impact of food and formulation on systemic exposure in children with drug-resistant developmental and epileptic encephalopathies
Epilepsia
Summary: Describing the pharmacokinetic profile of cannabidiol in 48 children with treatment-resistant epileptic encephalo...
11/05/2024
Purified cannabidiol as add-on therapy in children with treatment-resistant infantile epileptic spasms síndrome
Epilepsia
Summary: Efficacy and safety of Convupidiol® in 28 infants with drug- and ketogenic diet–resistant infantile spa...
03/05/2023
Cannabidiol in children with treatment-resistant epilepsy with myoclonic-atonic seizures
Epilepsia
Summary: Multicenter study evaluating the efficacy and tolerability of CONVUPIDIOL in patients with epilepsy with myocloni...
01/03/2021
Trabajo "Estudio randomizado, placebo controlado para tratamiento con cannabidiol como aad-on en la epilepsia resistente por Esclerosis Tuberosa" Autor: Thiele, E.A et al.
Epilepsia
Estudio de eficacia de cannabidiol en epilepsia refractaria por esclerosis tuberosa, con dosis de 25mg/k/d y 50 mg/kg/d vs...
25/05/2017
Paper: “Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome” By Dr. Orrin Devinsky
Epilepsia
Summary:In this double-blind, placebo-controlled trial, we randomly assigned 120 children and young adults with the Dravet synd...
19/11/2023
Paper: “A perspective on cannabinoids for treating epilepsy: Do they really change the landscape?” By Dr. Helen Cross
Epilepsia
Summary:In this paper,  Dr. Helen Cross, warns about the risks of artisanal preparations, not only due to the impossibilit...
11/10/2023
Paper: “Cannabis and epilepsy” By Dr. Rhys H. Thomas and Dr. Mark O. Cunningham
Epilepsia
Summary:Review on the “state of art” of Cannabis and epilepsy, warns about the differences between pharmaceutical c...
07/11/2017
Research Letter: “Labeling Accuracy of Cannabidiol Extracts Sold Online” By Marcel O. Bonn-Miller, PhD; Mallory J. E. Loflin, PhD; Brian F. Thomas, PhD
Epilepsia
Summary: Work made by researchers of UPenn in JAMA who performed a comparison between contents of commercialized products, foun...
30/09/2016
Paper: “Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol” “ By José A. S. Crippa, Ana C. S. Crippa, Jaime E. C. Hallak, Rocio Martín-Santos, and Antonio W. Zuardi”
Epilepsia
Summary:Work by Crippa and others, reporting 2 cases of THC intoxication due to artisanal preparations. It highlights the impor...

Convupidiol

CBD 100MG X ML

35 ML - Oral Solution

Each ml. of oral solution contains

  • Cannabidiol 100,00 mg
  • Vanilla flavor
  • Sesame oil
Download prospectus PDF

Professionals Contact

Complete the form and we will contact you shortly.